The pro-inflammatory cytokine IL-36γ was known before to be critically involved in several inflammatory disorders such as psoriasis (29, 44, 45), inflammatory bowel disease (23, 32, 44), rheumatoid arthritis (21), or systemic lupus erythematosus (SLE) (24). This evidence concerns the gene IL36G and psoriasis.